Charles Louis Wiseman, Executive, Ten Percent Owner at BriaCell Therapeutics, holds 13.38M shares in BriaCell Therapeutics (Ticker: TSE:BCT). Most recently, Charles Louis Wiseman Sold C$560,500 shares of BriaCell Therapeutics on Oct 18, 2016 for an estimated value of 112.30K.